Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized study of RO4389620 in type 2 diabetes mellitus
2005-002907-18Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of piragliatin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Roche. Primary endpoint: Change in HbA1c from baseline vs placebo. Started Sep 2005; status: completed.
02
Drugs
piragliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-002907-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002907-18.